new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Hoffman la Roche Inc patents

Recent patent applications related to Hoffman la Roche Inc. Hoffman la Roche Inc is listed as an Agent/Assignee. Note: Hoffman la Roche Inc may have other listings under different names/spellings. We're not affiliated with Hoffman la Roche Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "H" | Hoffman la Roche Inc-related inventors




Date Hoffman la Roche Inc patents (updated weekly) - BOOKMARK this page
12/08/16Compositions and uses thereof
12/17/15Substituted hetero-azepinones
12/10/15Antiproliferative benzo [b] azepin-2-ones
08/06/15Interleukin-2 fusion proteins and uses thereof
07/09/15Triazole carboxamides and uses thereof
06/18/15Inhibitors of hcv ns5a
02/12/15Antibodies for identifying and/or isolating at least one cell population
01/01/152'-4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
11/27/14Dual modulators of 5ht2a and d3 receptors
05/01/14Bivalent, bispecific antibodies
11/21/13Chromatography column support
10/10/13Antibodies for identifying and/or isolating at least one cell population
08/22/13Method for the identification of catechol o-methyltransferase modulators
07/18/13Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
07/18/13Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
07/11/13Pyridazine amide compounds
02/28/13Cation and anion exchange chromatography method
11/29/12Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc)
11/01/12Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent
08/30/12Combination therapy of a type ii anti-cd20 antibody with a proteasome inhibitor
01/26/12Method for avoiding glass fogging
11/24/11Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent
08/25/11Small scale shaker flask cultivation
08/18/11Combination therapy of a type ii anti-cd20 antibody with a proteasome inhibitor
07/28/11Methods to identify responsive patients
07/28/11Prevention and treatment of amyloidogenic diseases
07/21/11Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc)
07/07/11Antibodies against human epo receptor
06/16/11Antibodies against human epo receptor
04/14/11Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent
01/27/11Pyrrolidinyl derivatives and uses thereof
12/09/10Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc)
07/15/10Antibodies for identifying and/or isolating at least one cell population
07/16/09Antibodies for identifying and/or isolating at least one cell population







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Hoffman la Roche Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Hoffman la Roche Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';